Clinical significance of para-aortic lymph node dissection and prognosis in ovarian cancer. 2014

Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Hospital Affiliated to Hubei University of Arts and Science, Xiangyang, 441021, China.

Lymph node metastasis has an important effect on prognosis of patients with ovarian cancer. Moreover, the impact of para-aortic lymph node (PAN) removal on patient prognosis is still unclear. In this study, 80 patients were divided into groups A and B. Group A consisted of 30 patients who underwent PAN + pelvic lymph node (PLN) dissection, whereas group B consisted of 50 patients who only underwent PLN dissection. Analysis of the correlation between PAN clearance and prognosis in epithelial ovarian cancer was conducted. Nineteen cases of lymph node metastasis were found in group A, among whom seven cases were positive for PAN, three cases for PLN, and nine cases for both PAN and PLN. In group B, 13 cases were positive for lymph node metastasis. Our study suggested that the metastatic rate of lymph node is 40.0%. Lymph node metastasis was significantly correlated with FIGO stage, tumor differentiation, and histological type both in groups A and B (P < 0.05). In groups A and B, the three-year survival rates were 77.9% and 69.0%, and the five-year survival rates were 46.7% and 39.2%, respectively. However, the difference was not statistically significant (P > 0.05). The three-year survival rates of PLN metastasis in groups A and B were 68.5% and 41.4%, and the five-year survival rates were 49.7% and 26.4%, respectively. Furthermore, PLN-positive patients who cleared PAN had significantly higher survival rate (P = 0.044). In group A, the three-year survival rates of positive and negative lymph nodes were 43.5% and 72.7%, and the five-year survival rates were 27.2% and 58.5%, respectively. The difference was statistically significant (P = 0.048). Cox model analysis of single factor suggested that lymph node status affected the survival rate (P < 0.01), which was the death risk factor. Consequently, in ovarian carcinoma cytoreductive surgery, resection of the para-aortic lymph node, which has an important function in clinical treatment and prognosis of patients with ovarian cancer, is necessary.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001012 Aorta, Abdominal The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries. Abdominal Aorta,Abdominal Aortas,Aortas, Abdominal
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
January 1999, Hepato-gastroenterology,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
January 1994, Anticancer research,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
June 1996, Gynecologic oncology,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
November 2022, BMC surgery,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
May 2024, Indian journal of surgical oncology,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
April 2024, Surgery today,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
May 2003, Zhonghua wai ke za zhi [Chinese journal of surgery],
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
September 2021, World journal of surgery,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
July 1996, Nihon Sanka Fujinka Gakkai zasshi,
Xianxian Li, and Hui Xing, and Lin Li, and Yanli Huang, and Min Zhou, and Qiong Liu, and Xiaomin Qin, and Min He
January 1998, Hepato-gastroenterology,
Copied contents to your clipboard!